Abstract
The authors established apoptosis resistant COS–1, myeloma, hybridoma, and Friend leukemia cell lines by genetically engineering cells, aiming at more efficient protein production by cell culture. COS–1 cells, which are most widely used for eukariotic gene expression, were transfected with human bcl–2 gene. Both bcl–2 and mock transfected COS–1 cells were cultured at low (0.2%) serum concentration for 9 days. The final viable cell number of the bcl–2 transfected cells was ninefold of that of the mock transfectants. Both bcl–2 and mock transfectants were further transfected with the vector pcDNA-λ containing SV40 ori and immunoglobulin λ gene for transiently expressing λ protein. The bcl–2 expressing COS–1 cells produced more λ protein than the mock transfected COS–1 cells after 4 days posttransfection.
Mouse myeloma p3-X63-Ag.8.653 cells, which are widely used as the partner for preparing hybridoma, and hybridoma 2E3 cells were transfected with human bcl–2 gene. Both bcl–2 transfected myeloma and hybridoma survived longer than the corresponding original cells in batch culture. The bcl–2 transfected 2E3 cells survived 2 to 4 four days longer in culture, producing 1.5- to 4-fold amount of antibody in comparison with the mock transfectants.
Coexpression of bag–1 with bcl–2 improved survival of hybridoma 2E3 cells more than bcl–2 expression alone. The bag–1 and bcl–2 coexpressing cells produced more IgG than the the cells expressing bcl–2 alone.
Apoptosis of Friend murine erythroleukemia(F-MEL) cells was suppressed with antisense c-jun expression. The antisense c-jun expressing cells survived 16 days at non-growth state.
Keywords: apoptosis resistant, bag–1, bcl–2, COS–1, hybridoma, protein production
Full Text
The Full Text of this article is available as a PDF (56.9 KB).
References
- Duval D, Demangel C, Geahel I, Blondeau K, Marcaded A. Comparison of various methods for monitoring hybridoma cell proliferation. J Immunol Meth. 1990;134:177–185. doi: 10.1016/0022-1759(90)90379-a. [DOI] [PubMed] [Google Scholar]
- Franěk F, Chládková-Šrámková K. Apoptosis and nutrition: Involvement of amino acid transport system in repression of hybridoma cell death. Cytotechnology. 1995;18:113–117. doi: 10.1007/BF00744326. [DOI] [PubMed] [Google Scholar]
- Glacken MW, Adema E, Sinskey AJ. Mathematical descriptions of hybridoma culture kinetics: I. initial metabolic rates. Biotechnol Bioeng. 1988;32:491–506. doi: 10.1002/bit.260320412. [DOI] [PubMed] [Google Scholar]
- Itoh Y, Ueda H, Suzuki E. Overexpression of bcl-2, apoptosis suppressing gene: prolonged viable culture period of hybridoma and enhanced antibody production. Biotechnol Bioeng. 1995;48:118–122. doi: 10.1002/bit.260480205. [DOI] [PubMed] [Google Scholar]
- Karasuyama H, Kudo A, Melchers F. The proteins encoded by the VpreB and λ5 pre-B cell-specific genes can associate with each other and with μ heavy chain. J Exp Med. 1990;172:969–972. doi: 10.1084/jem.172.3.969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Makishima F, Terada S, Mikami T, Suzuki E. Interleukin-6 is antiproliferative to a mouse hybridoma cell line and promotive for its antibody productivity. Cytotechnology. 1992;10:15–23. doi: 10.1007/BF00376096. [DOI] [PubMed] [Google Scholar]
- Mellon P, Parker V, Gluzman Y, Maniatis T. Identification of DNA sequences required for transcription of SV40 host-vector system. Cell. 1981;27:279–288. doi: 10.1016/0092-8674(81)90411-6. [DOI] [PubMed] [Google Scholar]
- Mercille S, Massie B. Induction of apoptosis in nutrient-deprived cultures of hybridoma and myeloma cells. Biotechnol Bioeng. 1994;44:1140–1154. doi: 10.1002/bit.260440916. [DOI] [PubMed] [Google Scholar]
- Nunez G, London L, Hockenberry D, Alexander M, McKearn JP, Korshmeyer H. Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived haempoietic cell lines. J Immunol. 1990;144:3602–3610. [PubMed] [Google Scholar]
- Singh RP, Al-Rubeai M, Gregory CD, Emery AN. Cell death in bioreactors: a role for apoptosis. Biotechnol Bioeng. 1994;44:720–726. doi: 10.1002/bit.260440608. [DOI] [PubMed] [Google Scholar]
- Smith MJ, Prochownik EV. Inhibition of c-jun causes reversible proliferative arrest and withdrawal from the cell cycle. Blood. 1992;79:2107–2115. [PubMed] [Google Scholar]
- Suzuki E, Ollis DF. Enhanced antibody production at slowed growth rates: experimental demonstration and a simple structured model. Biotechnol Prog. 1990;6:231–236. doi: 10.1021/bp00003a013. [DOI] [PubMed] [Google Scholar]
- Takahashi K, Terada S, Ueda H, Makishima F, Suzuki E. Growth rate suppression of cultured mammalian cells enhances protein productivity. Cytotechnology. 1994;12:1–8. doi: 10.1007/BF00762379. [DOI] [PubMed] [Google Scholar]
- Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC. Cloning and functional analysis of BAG-1: a novel Bcl-2 binding protein with anti-cell death activity. Cell. 1995;80:279–284. doi: 10.1016/0092-8674(95)90410-7. [DOI] [PubMed] [Google Scholar]
- Tohyama N, Karasuyama H, Tada T. Growth autonomy and tumorigenicity of interleukin-6-dependent B cells transfected with interleukin-6 cDNA. J Exp Med. 1990;171:389–400. doi: 10.1084/jem.171.2.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tsujimoto Y. Stress-resistance conferred by high level of bcl-2a protein in human B lymphoblastoid cell. Oncogene. 1989;4:1331–1336. [PubMed] [Google Scholar]
- Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalise pre-B cells. Nature. 1988;335:440–442. doi: 10.1038/335440a0. [DOI] [PubMed] [Google Scholar]
- Vomastek T, Franěk F. Kinetics of development of spontaneous apoptosis in B cell hybridoma cultures. Immunol Lett. 1993;35:19–24. doi: 10.1016/0165-2478(93)90142-o. [DOI] [PubMed] [Google Scholar]